Molecular cloning and regulation of expression of two novel mouse CYP4F genes: Expression in peroxisome proliferator-activated receptor α-deficient mice upon lipopolysaccharide and clofibrate challenges

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 2, 2001, Pages 542-550

  Cui, Xiaoming ^a   Kawashima, Hidenori ^b   Barclay, Thomas B ^c   Peters, Jeffrey M ^d   Gonzalez, Frank J ^d   Morgan, Edward T ^c   Strobel, Henry W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; CYTOCHROME P450 4F; CYTOCHROME P450 ISOENZYME; ICOSANOID; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; LIPOXIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROSTAGLANDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HYDROXYLATION; MALE; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION;

EID: 0035146291     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent
2. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643
3. Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles
4. Identification of a new P450 subfamily, CYP4F1, expressed in rat hepatic tumors
5. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
6. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals
7. A novel human cytochrome P4504F isoform (CYP4F11): cDNA cloning, expression and genomic structure characterization
8. The PPARalpha-leukotriene B4 pathway to inflammation control
9. p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha
10. Activation of hepatic NF-kappaB by the herbicide Dicamba (2-methoxy-3,6-dichlorobenzoic acid) in female and male rats
11. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
12. Inhibition of the Kupffer cell inflammatory response by acute ethanol: NF-kappa B activation and subsequent cytokine production
13. Leukotriene B4 omega-hydroxylase activity in polymorphonuclear leukocytes from patients with inflammatory bowel disease
14. The peroxisome proliferator-activated receptor: Retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs
15. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines
16. Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4
17. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
18. Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain
19. cDNA cloning of three new forms of rat brain cytochrome P450 belonging to the CYP4F subfamily
20. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega-hydroxylase
21. Purification and characterization of recombinant rat hepatic CYP4F1
22. Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver
23. Purification and characterization of recombinant human neutrophil leukotriene B4 omega-hydroxylase (cytochrome P450 4F3)
24. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
25. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
26. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
27. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity
28. Regulation of cytochromes P450 during inflammation and infection
29. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid
30. Properties of leukotriene B4 20-hydroxylase from polymorphonuclear leukocytes
31. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
32. WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes
33. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450
34. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
35. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates
36. Differential activation of peroxisome proliferator-activated receptors by eicosanoids